Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -23.62x is 69% above its 3-year average of -76.47x, near the high end of its 3-year range (-557.93x–8.65x).
As of the fiscal period ended Friday, March 31, 2023. 91.82% above its 12-month average of -288.77x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2023 (2023-03-31): -23.62x.
INTEREST COVERAGE RATIO
-23.62x
INTEREST COVERAGE RATIO AVG TTM
-288.77x
INTEREST COVERAGE RATIO AVG 3Y
-83.32x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+91.82%
CURRENT VS 3Y AVG
+71.64%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.84x
median of 371 covered companies
CURRENT VS SECTOR MEDIAN
-388.11%
vs the sector median at left
908 Devices Inc.
Market Cap
$513.25M
Interest Coverage Ratio
-23.62x
TTM Avg
-288.77x
3Y Avg
-83.32x
5Y Avg
N/A
Market Cap
$507.55M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$516.46M
Interest Coverage Ratio
-57.76x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$521.76M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$498.75M
Interest Coverage Ratio
-192.50x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$531.34M
Interest Coverage Ratio
-69.85x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$533.01M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$473.36M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 908 Devices Inc. (MASS) | $513.25M | -23.62x | -288.77x | -83.32x | N/A |
| Monopar Therapeutics Inc. (MNPR)vs › | $507.55M | N/A | N/A | N/A | N/A |
| Altimmune, Inc. (ALT)vs › | $516.46M | -57.76x | N/A | N/A | N/A |
| Immix Biopharma, Inc. (IMMX)vs › | $521.76M | N/A | N/A | N/A | N/A |
| Allogene Therapeutics, Inc. (ALLO)vs › | $498.75M | -192.50x | N/A | N/A | N/A |
| Crescent Biopharma, Inc. (CBIO)vs › | $531.34M | -69.85x | N/A | N/A | N/A |
| Delcath Systems, Inc. (DCTH)vs › | $533.01M | N/A | N/A | N/A | N/A |
| Evolus, Inc. (EOLS)vs › | $473.57M | -1.91x | N/A | N/A | N/A |
| Bright Minds Biosciences Inc. (DRUG)vs › | $473.36M | N/A | N/A | N/A | N/A |
| Arvinas, Inc. (ARVN)vs › | $471.65M | N/A | N/A | N/A | N/A |
Interest Coverage
-23.6x
Debt/Equity
0.03
Current Ratio
2.67
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-03-31 | -23.62x |
| 2022-12-31 | -169.48x |
| 2022-09-30 | -216.79x |
| 2022-06-30 | -557.93x |
| 2022-03-31 | -476.05x |
| 2021-12-31 | -88.20x |
| 2021-09-30 | -170.19x |
| 2021-06-30 | -191.15x |
| 2021-03-31 | -33.01x |
| 2020-12-31 | -15.93x |
| 2020-09-30 | -5.28x |
| 2020-06-30 | 8.65x |
| 2020-03-31 | -11.47x |
| 2019-12-31 | -1.22x |
